Skip to Content

ChampionX Corp

CHX: XNAS (USA)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
$97.00GlbjhGctrhvtw

ChampionX Earnings: New Product Adoption Contributed to Improved Profitability

No-moat ChampionX posted solid first-quarter results, with revenue increasing 10% year over year and firmwide adjusted EBITDA margin increasing 400 basis points over the same period. Sequentially, top-line growth dropped 4% due to standard seasonality in the firm’s non-North American markets, yet the firm’s adjusted EBITDA margin jumped 40 basis points owing to favorable pricing movements and internal productivity gains. We remain optimistic regarding ChampionX’s 2023 prospects and thus maintain our $33 fair value estimate following results.

Free Trial of Morningstar Investor

Get our analysts’ objective, in-depth, and continuous investment coverage of CHX so you can make buy / sell decisions free of market noise.

Start Free Trial

Sponsor Center